Genesco stock gains after Q2 turnaround and Truist price target cut

Genesco stock is trading in the mid-30 dollar range after a stronger Q2 FY27 operating performance and a fresh Truist price target cut to 38 dollars, leaving the retailer in a hold-rated, value-sensitive zone for investors.

Genesco stock (ISIN US3715321032) is trading in the mid-30 dollar range as of September 4, 2026, after the Nashville-based footwear retailer reported a marked improvement in second quarter fiscal 2027 operating results and analysts reiterated a cautious hold stance with modest upside.

Q2 FY27 figures show profit recovery

According to a performance summary reported on September 4, 2026, Genesco generated net sales of 529.9 million USD in the second quarter of fiscal 2027, covering the three months ended August 1, 2026, a decline of 3 percent year on year that was driven primarily by net store closures and reduced licensed sales. The same overview highlights that operating income turned positive at 3.6 million USD, compared with an operating loss of 14.4 million USD in Q2 FY26, representing a swing of 18.0 million USD in operating performance year on year.

Gross margin for Q2 FY27 reached 51.4 percent on a reported basis, boosted by benefits such as tariff refunds, while adjusted gross margin stood at 47.2 percent, underscoring a structurally stronger profitability profile in merchandising and sourcing even against a slightly softer revenue base. In the company’s core banners, Journeys and Johnston & Murphy posted positive comparable sales in the quarter, indicating that underlying demand trends in key concepts were healthier than the headline 3 percent top-line decline suggests.

Guidance raised to high end of FY27 EPS range

Reflecting the improved operating trends, Genesco raised its fiscal 2027 adjusted diluted earnings per share guidance to the high end of the previously communicated range of 2.00 to 2.40 USD, as highlighted in the same September 4, 2026 report. Management now expects operating income for the year to come in at the high end of the earlier 34 million to 40 million USD range, supported by stronger gross margins and disciplined cost control, while projecting total sales to decline approximately 2 percent and comparable sales to be roughly flat versus prior guidance for a 1 to 2 percent increase.

The balance sheet also shows progress: Genesco ended the quarter with cash of 57.1 million USD, up from 41.0 million USD a year earlier, and total debt reduced to 15.8 million USD from 71.0 million USD, which significantly lowers financial leverage and improves flexibility for inventory investment, store refreshes and potential shareholder returns. For investors, the combination of higher cash, sharply lower debt and a swing to positive operating income in Q2 FY27 is a visible inflection compared with Q2 FY26, even though management still expects a low-single-digit decline in full-year sales.

Analyst view and price targets around Truist update

On September 4, 2026, Truist Financial lowered its price target for Genesco shares to 38 USD from 40 USD while maintaining a hold rating, a move that still implies upside from the most recent share price level in the mid-30 dollar range. Data compiled by MarketBeat notes that the revised 38 USD target corresponds to an indicated upside of about 7.7 percent versus a referenced trading level of 35.28 USD, and that the broader analyst consensus rating on Genesco remains hold with an average target price of 36 USD.

A separate overview of GCO compiled by a valuation-focused portal on September 4, 2026 indicates that Genesco’s shares were trading at around 35.37 USD compared with an internally calculated fair value estimate of 30.85 USD, suggesting that the stock was considered approximately 14.6 percent overvalued on that methodology. The same analysis underscores that Truist Securities maintained its rating while trimming the price target, a combination that fits with the impression of a stock that has re-rated on improving margins but is not yet seen as a clear growth story.

For investors in German-language markets, a profile of Genesco circulating on a European financial portal as of September 4, 2026 cites a last closing price of 34.44 USD and an average analyst target of 39.67 USD, implying a gap of just over 15 percent between the share price and the mean target. This consensus snapshot also shows that four analysts cover the stock with an overall recommendation in the accumulate or hold band, illustrating that the market’s view sits between value opportunity and caution.

Journeys as core retail concept

Genesco’s key consumer-facing concept is Journeys, a specialty retailer focused on youth-oriented footwear, apparel and accessories that operates stores primarily across the United States and certain international markets. The Q2 FY27 figures reported on September 4, 2026 noted that Journeys delivered positive comparable sales in the quarter, which is notable given that the group’s total net sales declined by 3 percent year on year to 529.9 million USD. For investors, a banner that manages positive comps while the broader portfolio experiences slight revenue pressure is an important indicator that Genesco’s focus on targeted concepts and differentiated assortments can support resilience in a competitive footwear market.

Genesco stock level and valuation context

Market data compiled around September 4, 2026 indicate that Genesco stock recently traded between about 34.5 USD and 35.4 USD, with one valuation overview highlighting a price point of 35.37 USD against a fair value estimate of 30.85 USD and an analyst alert referencing a level of 35.28 USD in the context of the Truist price target reduction. With the Truist target now at 38 USD and the broader consensus around 36 USD, the share price in the mid-30 dollar range sits below the top-down target band but above at least one fair-value estimate, illustrating the tension between margin recovery and still moderating sales.

Genesco stock key data

• Company: Genesco Inc.
• ISIN: US3715321032
• Ticker: GCO
• Trading venue: NYSE
• Price (as of September 4, 2026): 35.28 USD
• Market capitalization: [value] USD (as of September 4, 2026)
• Sector / Industry: Consumer Discretionary / Specialty Retail
• Index membership: Small-cap retail universe (United States)